Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Toxicol Lett ; 344: 18-25, 2021 Jun 15.
Article in English | MEDLINE | ID: mdl-33689779

ABSTRACT

Recent findings have revealed that exposure to environmental contaminants may result in obesity and pose a health threat to the general public. As the activity of transient receptor potential channels (TRPs) plays a permissive role in adipogenesis, the interactions between TRPs and some food pollutants, i.e. bisphenol A, di (2-ethylhexyl) phthalate, zearalenone, and zeranol at 10 µM were investigated in the present study. TRP-V1,-V3, -C4 and -C6 are reported to be differentially expressed in the adipocyte differentiation, and immunoblotting was performed to quantify changes in these TRPs affected by the pollutants. Our result indicated that the mycoestrogen zeranol or α-zearalanol suppressed the expression of the V1 and C6 isoforms. Subsequently, confocal microscopy was used to measure the calcium inflow repressed by zeranol from 0.1 µM to 10 µM. Oil Red O staining was used to determine the differentiation of 3T3 L1 preadipocytes. Zeranol could suppress the expression of TRP-V1 and -C6 protein and inhibit the associated flow of calcium into the cytosol of 3T3 L1 cells. Its IC50 value for inhibiting calcium inflow stimulated by 40 µM capsaicin or 10 µM GSK1702934A was estimated to be around 6 µM. Reduced TRP-V1 or -C6 activity might result in promoting adipogenesis. In conclusion, this study demonstrated that zeranol could potentiate fat cell differentiation through antagonizing TRP-V1 and -C6 activities.


Subject(s)
Estrogens, Non-Steroidal/toxicity , Transient Receptor Potential Channels/antagonists & inhibitors , Zeranol/toxicity , 3T3-L1 Cells , Animals , Biological Transport/drug effects , Calcium/metabolism , Capsaicin/pharmacology , Drug Tapering , Estradiol/pharmacology , Estrogens, Non-Steroidal/administration & dosage , Gene Expression Regulation/drug effects , Inhibitory Concentration 50 , Mice , Protein Isoforms/genetics , Protein Isoforms/metabolism , Transient Receptor Potential Channels/agonists , Transient Receptor Potential Channels/metabolism , Zeranol/administration & dosage
2.
Chemosphere ; 253: 126772, 2020 Aug.
Article in English | MEDLINE | ID: mdl-32464760

ABSTRACT

Zeranol is an approved but controversial growth-promoting agent for livestock in North America. It is a mycotoxin metabolite secreted by the Fusarium family fungi. The regulatory bodies in this region have established the acceptable daily intake and exposure below the level would not significantly increase the health risk for humans. However, their European counterparts have yet to establish an acceptable level and do not permit the use of this agent in farm animals. Given the growth-promoting ability of zeranol, its effect on energy metabolism was investigated in the current study. Our results indicated that zeranol could induce glucose transporter type 4 (GLUT4) expression in 3T3 L1 cells at 10 µM and initiate the translocation of the glucose transporter to the membrane as assayed by confocal microscopy. The translocation was likely triggered by the increase of GLUT4 and p-Akt. The insulin signal transduction pathway of glucose translocation was analyzed by Western blot analysis. Since no increase in the phosphorylated insulin receptor substrate in zeranol-treated cells was evidenced, the increased p-Akt and GLUT4 amount should be the mechanism dictating the GLUT4 translocation. In summary, this study showed that zeranol could perturb glucose metabolism in differentiated 3T3 L1 adipocytes. Determining the growth-promoting mechanism is crucial to uncover an accepted alternative to the general public.


Subject(s)
Glucose Transporter Type 4/metabolism , Plant Growth Regulators/toxicity , Zeranol/toxicity , 3T3-L1 Cells , Adipocytes , Animals , Antigens, CD , Carbohydrate Metabolism , Glucose/metabolism , Insulin/metabolism , Livestock , Mice , North America , Phosphorylation , Receptor, Insulin/metabolism , Signal Transduction/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL
...